Elizabeth Barbosa

712 total citations
46 papers, 568 citations indexed

About

Elizabeth Barbosa is a scholar working on Molecular Biology, Biochemistry and Parasitology. According to data from OpenAlex, Elizabeth Barbosa has authored 46 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Biochemistry and 10 papers in Parasitology. Recurrent topics in Elizabeth Barbosa's work include Traditional and Medicinal Uses of Annonaceae (12 papers), Parasitic Infections and Diagnostics (10 papers) and Natural product bioactivities and synthesis (8 papers). Elizabeth Barbosa is often cited by papers focused on Traditional and Medicinal Uses of Annonaceae (12 papers), Parasitic Infections and Diagnostics (10 papers) and Natural product bioactivities and synthesis (8 papers). Elizabeth Barbosa collaborates with scholars based in Mexico, United States and Bolivia. Elizabeth Barbosa's co-authors include Fernando Calzada, Claudia Velázquez, Rafael K. Campos, Normand García-Hernández, José Correa‐Basurto, Miguel Ángel Serra Valdés, Rosa María Ordóñez‐Razo, David Méndez-Luna, Rafael O.P. de Campos and Roberto Cedillo‐Rivera and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Elizabeth Barbosa

42 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Barbosa Mexico 16 172 144 92 90 86 46 568
Claudia Velázquez Mexico 14 154 0.9× 158 1.1× 87 0.9× 77 0.9× 70 0.8× 38 486
Suriya P. Singh India 15 279 1.6× 162 1.1× 58 0.6× 78 0.9× 124 1.4× 32 670
Moses N. Ngemenya Cameroon 13 154 0.9× 344 2.4× 132 1.4× 45 0.5× 110 1.3× 36 608
Smith B. Babiaka Cameroon 14 278 1.6× 222 1.5× 76 0.8× 34 0.4× 43 0.5× 30 655
Long Cui China 11 301 1.8× 117 0.8× 37 0.4× 43 0.5× 37 0.4× 34 581
Oyindamola O. Abiodun Nigeria 13 123 0.7× 283 2.0× 107 1.2× 44 0.5× 84 1.0× 53 663
Noor Rain Abdullah Malaysia 14 231 1.3× 270 1.9× 49 0.5× 32 0.4× 77 0.9× 29 824
Piya Paul Mudgal India 15 232 1.3× 175 1.2× 98 1.1× 129 1.4× 23 0.3× 30 822
E.N.M. Njagi Kenya 19 196 1.1× 494 3.4× 167 1.8× 64 0.7× 143 1.7× 37 1.1k
María Julia Verde‐Star Mexico 14 221 1.3× 278 1.9× 140 1.5× 40 0.4× 55 0.6× 70 595

Countries citing papers authored by Elizabeth Barbosa

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Barbosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Barbosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Barbosa more than expected).

Fields of papers citing papers by Elizabeth Barbosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Barbosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Barbosa. The network helps show where Elizabeth Barbosa may publish in the future.

Co-authorship network of co-authors of Elizabeth Barbosa

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Barbosa. A scholar is included among the top collaborators of Elizabeth Barbosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Barbosa. Elizabeth Barbosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calzada, Fernando, et al.. (2025). Anti-lymphoma Activity of Acyclic Terpenoids and Its Structure–Activity Relationship: In Vivo, In Vitro, and In Silico Studies. International Journal of Molecular Sciences. 26(12). 5683–5683.
2.
Calzada, Fernando, Normand García-Hernández, Elihú Bautista, et al.. (2024). Understanding the Molecular Mechanisms of Incomptine A in Treating Non-Hodgkin Lymphoma Associated with U-937 Cells: Bioinformatics Approaches, Part I. Pharmaceuticals. 18(1). 5–5.
3.
Calzada, Fernando, et al.. (2024). Caryophyllene Oxide, a Bicyclic Terpenoid Isolated from Annona macroprophyllata with Antitumor Activity: In Vivo, In Vitro, and In Silico Studies. International Journal of Molecular Sciences. 25(24). 13355–13355. 2 indexed citations
4.
5.
6.
Calzada, Fernando, Elihú Bautista, Sergio Hidalgo‐Figueroa, et al.. (2022). Understanding the Anti-Diarrhoeal Properties of Incomptines A and B: Antibacterial Activity against Vibrio cholerae and Its Enterotoxin Inhibition. Pharmaceuticals. 15(2). 196–196. 4 indexed citations
7.
Valdés, Miguel Ángel Serra, Francisco Javier Alarcón-Aguilar, Ángeles Fortis-Barrera, et al.. (2022). Antihyperglycemic Effects of Salvia polystachya Cav. and Its Terpenoids: α-Glucosidase and SGLT1 Inhibitors. Plants. 11(5). 575–575. 9 indexed citations
8.
Calzada, Fernando, Normand García-Hernández, Sergio Hidalgo‐Figueroa, et al.. (2022). Expanding the Study of the Cytotoxicity of Incomptines A and B against Leukemia Cells. Molecules. 27(5). 1687–1687. 3 indexed citations
9.
10.
Calzada, Fernando, Elihú Bautista, Sergio Hidalgo‐Figueroa, et al.. (2021). Antilymphoma Effect of Incomptine A: In Vivo, In Silico, and Toxicological Studies. Molecules. 26(21). 6646–6646. 8 indexed citations
11.
Barbosa, Elizabeth, Edgar E. Lara‐Ramírez, Alma D. Paz-González, et al.. (2021). Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase. International Journal of Molecular Sciences. 22(11). 5943–5943. 17 indexed citations
12.
Ordóñez‐Razo, Rosa María, Fernando Calzada, Aida Solı́s, et al.. (2021). Antitumor Potential of Annona muricata Linn. An Edible and Medicinal Plant in Mexico: In Vitro, In Vivo, and Toxicological Studies. Molecules. 26(24). 7675–7675. 7 indexed citations
13.
Valdés, Miguel Ángel Serra, et al.. (2020). Antihyperglycemic Effects of Annona diversifolia Safford and Its Acyclic Terpenoids: α-Glucosidase and Selective SGLT1 Inhibitiors. Molecules. 25(15). 3361–3361. 15 indexed citations
14.
Calzada, Fernando, Miguel Ángel Serra Valdés, Claudia Velázquez, et al.. (2020). Phytochemical analysis, antipropulsive and antilymphoma activities of leaves extract of Annona cherimola miller. Pharmacognosy Magazine. 16(69). 317. 1 indexed citations
15.
Calzada, Fernando, Miguel Ángel Serra Valdés, Normand García-Hernández, et al.. (2020). Secondary metabolites and biological properties of Annona muricata. Revista Brasileira de Farmacognosia. 30(2). 305–311. 8 indexed citations
16.
Calzada, Fernando, Miguel Ángel Serra Valdés, Normand García-Hernández, et al.. (2019). Antihyperglycemic activity of the leaves from annona diversifolia Safford. and farnesol on normal and alloxan-induced diabetic mice*. Pharmacognosy Magazine. 15(62). 5. 12 indexed citations
17.
Calzada, Fernando, José Correa‐Basurto, Elizabeth Barbosa, et al.. (2017). Antiprotozoal Activities of Tiliroside and other Compounds from Sphaeralcea angustifolia (Cav.) G. Don.. Europe PMC (PubMed Central). 9(2). 133–137. 16 indexed citations
18.
Calzada, Fernando, Rosa María Ordóñez‐Razo, Claudia Velázquez, et al.. (2017). Antihyperglycemic activity of the leaves from Annona cherimola miller and rutin on alloxan-induced diabetic rats. Pharmacognosy Research. 9(1). 1–1. 43 indexed citations
19.
20.
Drago-Serrano, María Elisa, et al.. (2008). La lactoferrina como modulador de la respuesta inmunitaria. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 33(2). 71–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Velázquez Breakdown of academic impact, for papers by Suriya P. Singh Breakdown of academic impact, for papers by Moses N. Ngemenya Breakdown of academic impact, for papers by Smith B. Babiaka Breakdown of academic impact, for papers by Long Cui Breakdown of academic impact, for papers by Oyindamola O. Abiodun Breakdown of academic impact, for papers by Noor Rain Abdullah Breakdown of academic impact, for papers by Piya Paul Mudgal Breakdown of academic impact, for papers by E.N.M. Njagi Breakdown of academic impact, for papers by María Julia Verde‐Star
Rankless by CCL
2026